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Abstract
Background: Strenuous physical activity activates the participant’s immune responses; however, few studies exist,
observing exercise-induced simultaneous changes in mediators of inflammation.
Methods: We examined individual responses in soluble urokinase-type plasminogen activator receptor (suPAR), a
marker of immune activation, soluble endocytic receptor for haptoglobin-hemoglobin complexes (CD163), a marker
of monocyte-macrophage activation, C-reactive protein (CRP), and pro- and anti-inflammatory cytokines from blood
samples drawn at baseline, at 3- and 48-h post-races from recreational runners who successfully completed the
marathon (199 ± 8 min, n = 4) or half-marathon (132 ± 4 min, n = 4) run. For comparisons, biomarkers reflecting
muscle, heart, kidney, and liver functions were measured.
Results: Significant 3-h post-race increases occurred in levels of suPAR (p < 0.01), CD163 (p < 0.05), white blood cells
(p < 0.001), pro-inflammatory cytokines, interleukin-6 (IL-6) (p < 0.001), IL-8 (p < 0.05), and anti-inflammatory cytokine
IL-10 (p < 0.05), whereas tumor necrosis factor-α (TNF-α) and transforming growth factor-β (TGF-β) remained relatively
stable. Full-marathon running lead to more pronounced increases in suPAR, CD163, IL-8, and IL-10 than half-marathon
running. In addition, 3-h post-race increases of all these parameters correlated significantly with changes in serum
TNF-α and cortisol. The 48-h levels of serum suPAR and both pro- and anti-inflammatory cytokines had decreased to
baseline levels, whereas CRP, a marker of acute phase response, increased in those with the most prominent IL-6 and
IL-10 elevations in their preceding samples. The highest suPAR, CRP, IL-6, TNF-α, IL-10, and cortisol levels were noted in
the individual with the most severe post-race fatigue.
Conclusions: Prolonged running increases mediators of inflammation in an exercise-dose-dependent manner which
should be considered in the assessment of health status of physically active individuals after recent acute bouts of
strenuous exercise.
Key Points
– Marathon and half-marathon running lead to dis-
tinct changes in mediators of inflammation in an
exercise-dose-dependent manner.
– Alterations in the balance between mediators of
inflammation may contribute to the post-race
reactivity of the immune system and health status
in individuals participating in such events.
Background
Although physical activity is widely acknowledged to be
an important part of a healthy lifestyle, the required doses
of activity leading to beneficial health effects remain as an
issue of controversy [1–4]. Long-distance running and
associated competitive events are currently attracting
ever-increasing numbers of participants, who present with
significant differences in their training backgrounds. Con-
sequently, marked inter-individual variation may also be
expected to occur in the acute health effects brought
about by such strenuous physical activity.
Several previous studies among marathon or ultra-
marathon runners have emphasized potential acute
health threats related to vigorous exercise, including
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the development of muscle, heart, or kidney injury [5–7].
As yet, however, relatively little is known on simultaneous
comparisons of individual responses in the mediators of
inflammation and on the interactions between such re-
sponses and other biomarkers of organ health [8–11]. More
information is also needed on the magnitude of changes in
such biomarkers as a result of either marathon or half-
marathon running by non-elite recreational runners.
Recent studies have indicated that IL-6, which is widely
recognized as a pro-inflammatory cytokine [12], may also
have a role as a myokine with anti-inflammatory proper-
ties [9, 11]. Previous researchers suggest that aerobic exer-
cise can provoke an IL-6 response from muscle cells, and
this finding may be associated with exercise-associated
metabolic changes, adaptation to training, and possibly
preconditioning individuals against myocardial ischemia-
reperfusion injury [9, 11, 13]. It has further been proposed
that such responses can be related to the intensity of the
exercise and mediate both autocrine and paracrine bene-
fits of training [9, 11]. While IL-6 levels are known to
increase after endurance exercise, relatively little has been
known on the comparisons between IL-6 and other cyto-
kines and mediators of inflammation under such condi-
tions. Recently, novel biomarkers of immune function,
which in clinical studies have attracted interest as more
specific tools to discriminate inflammation and associated
disease severity, have also been developed [14–17]. Soluble
urokinase-type plasminogen activator receptor (suPAR),
which is expressed on various immunologically active
cells, including monocytes, lymphocytes, and macro-
phages, is elevated in conditions involving the activation
of the immune system [14–16]. Haptoglobin-hemoglobin
complex (CD163) protein is an endocytic receptor for
haptoglobin-hemoglobin complexes, and it is expressed
solely on macrophages and monocytes [17]. It has been
suggested to play a role in preventing hemoglobin-
induced toxicity during physiological and pathological
hemolyses [17]. Serum soluble CD163 increases in condi-
tions with the intense involvement of macrophages pos-
sibly reflecting anti-inflammatory signaling activity. It may
also contribute to protective mechanisms initiated under
conditions of oxidative-radical burden [18]. However,
studies on serum suPAR and CD163 under conditions
of strenuous physical activity have not yet been made
available.
In order to shed further light on the function of the im-
mune system in response to acute bouts of exercise, we
compared pre- and post-race values of both conventional
and novel biomarkers of immune activation, including
suPAR, CD163, pro-inflammatory (IL-6, IL-8, tumor necro-
sis factor-α [TNF-α]), anti-inflammatory (IL-10, growth
factor-β [TGF-β]) cytokines and markers of muscle, heart,
kidney, and liver status, among typical casual long-distance
running event participants. In our sample, we chose to
examine representatives from both full (42.2 km) and half-
marathons. Although both distances are significant chal-
lenges for recreational runners, they still may be expected
to reveal distinct differences in their associated biological
and medical responses.
Methods
We followed eight healthy male volunteers who ran ei-
ther a marathon (n = 4) or a half-marathon (n = 4) race.
The characteristics of the participants are summarized
in Table 1. None of the subjects had any history of
known diseases or reported any intake of medication
due to illnesses. Except for two marathon participants,
none of the subjects had previous full- or half-marathon
race experience. All marathon runners were, however,
fitness enthusiasts with frequent participations in different
types of amateur sports activities including 10-k jogging
events, cross-country skiing, or amateur tennis. In com-
parison, the half-marathon participants were recreational
casual runners devoid of any such experience. All subjects
gave their informed consent after detailed discussions on
the risks, benefits, and alternatives of the experimental
protocol. The protocol was approved by the Northern
Osthrobothnia Hospital District (PPSHP) Institutional Re-
view Board, Oulu, Finland, and the study was conducted
according to the provisions of the Declaration of Helsinki.
The running trial took place in a local race with fewer
than 1000 participants on a relatively flat, sea-level road
course which was paired with half-marathoners doing
one and marathoners doing two loops on an accurately
measured course. The race commenced at 12 noon. The
weather was partly cloudy with the temperature ranging
from 18 to 21 °C. Relative humidity was 40–50 %, and
wind speed fell between 15 and 22 km/h. During the
activity, liberal amounts of fluids and exogenous carbo-
hydrates were available ad libitum. Medical care services,
as set up by experienced healthcare professionals, were
available along the route throughout the race day. In
addition, a medical surveillance system specifically for
the study participants was established by the investiga-
tors (ON, TJ). A fully equipped medical tent was avail-
able at the finishing area. Additional medical care and
blood sampling facilities were located at the Central
Hospital next to the site of the running event. Medical
examinations of the study participants were carried out
before the race, within 2 h after finishing and 1 week after
the race. Blood samples were drawn by a trained laboratory
nurse on the day before and 2 days after the race after an
overnight fast and a 15-min rest period prior to sampling.
On the race day, blood samples were also collected 3-h
post-race and before a post-race meal was provided. Serum
was separated by centrifugation (1500×g for 10 min) and
was subsequently stored at –70 °C prior to the determin-
ation of the various biomarkers. All measurements were
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carried out in a SFS-EN ISO/IEC 17025:2005- and SFS-
EN ISO 15189:2007-accredited laboratory. Serum suPAR
levels were measured using the suPARnostic enzyme-
linked immunosorbent assay (ELISA) kit according to the
instructions of the manufacturer (Virogates, Birkerød,
Denmark). The measurements of CD163 were carried out
using Quantikine human CD163 ELISA assay (R&D Sys-
tems, Abingdon Science Park, UK). The concentrations of
interleukins (Il-6, IL-8, IL-10, TNF-α, TGF-β) in serum
were determined using Quantikine high sensitivity ELISA
kits (R&D Systems, Abingdon, UK). Serum C-reactive
protein (CRP), biomarkers of muscle, heart, kidney, and
liver functions, serum electrolytes, cortisol, and blood lac-
tate were carried out using standard clinical chemical
methods on Abbott Architect c8000, Abbott Architect
i1000 (Abbott Diagnostics, Abbott Laboratories, Abbott
Park, IL, USA), or Cobas 411 (Roche Diagnostics, Basel,
Switzerland) automated clinical chemistry analyzers. Sam-
ples of EDTA-anticoagulated blood were used for the de-
termination of blood cell counts (Sysmex automated
Hematology Analyzer, Sysmex Corporation).
The values presented are reported as mean ± standard
deviation (SD). Comparisons were made using paired or
unpaired t tests, as required. Correlations between post-
race values were calculated using Pearson product-moment
correlation coefficients (r) and after an adjustment for base-
line variability using percent change (pre-post) for each
outcome variable. A p value of <0.05 was considered statis-
tically significant. Statistical analyses were carried out on
Stata statistics data analysis software (StataCorp LP, TX,
USA).
Results
The mean finishing time for the marathon was 199 ±
9 min (range 188–209 min) and for the half-marathon
132 ± 5 min (range 126–136 min) (Table 1). Post running,
clinical examinations indicated pain and stiffness in the
quadriceps areas in all runners, with no other clinical
symptoms or signs of generalized fatigue, except for one
marathon runner who needed intravenous hydration
(300 mL/h) and post-race monitoring in a hospital setting.
Personal feelings expressed by all participants suggested a
rapid recovery, which was completed within 7 days.
Figure 1 summarizes the individual changes in the vari-
ous biomarkers of inflammatory status in all runners.
Comparison of the data at baseline and at 3-h post-race
indicated significant increases in suPAR (p < 0.01), CD163
(p < 0.05), white blood cells (p < 0.001), pro-inflammatory
cytokines, IL-6 (p < 0.01), and IL-8 (p < 0.05) whereas not in
TNF-α levels (Fig. 1). Anti-inflammatory cytokine, IL-10,
also showed a significant increase from baseline (p < 0.05)
while TGF-β remained relatively stable. When comparing
the data obtained from full- and half-marathon, mara-
thon running was found to lead to more pronounced
increases in serum suPAR (p < 0.05), CD163 (p < 0.05),
IL-8 (p < 0.01), and IL-10 (p < 0.05) (Fig. 1). Both
types of exercises increased white blood cell counts in
a rather similar manner. In 48-h post-race samples,
serum suPAR and cytokine markers had decreased to
baseline levels, whereas an increase in serum CRP
was noted especially in those marathon runners with
the highest IL-6 and IL-10 levels in their preceding
sample. The highest levels of serum suPAR, CRP, IL-
6, TNF-α, IL-10, and cortisol were noted in the indi-
vidual who also suffered from symptoms of post-race
fatigue (Fig. 1).
A summary of the post-race changes in the various la-
boratory tests of different organ functions among mara-
thon and half-marathon runners is shown in Table 2. The
changes were most striking in biomarkers of muscle and
heart injury with marked differences between the two
subgroups of runners. In 3-h post-race samples, positive
correlations were observed between the changes in the
different mediators of inflammation (suPAR, CD163, IL-8,
TNF-α, IL-10), serum uric acid and cortisol levels (Table 3).
Post-race changes in mediators of inflammation also coin-
cided with marked changes in serum myoglobin and tropo-
nin T (Fig. 1, Table 2).
Discussion
While physical activity in proper amounts promotes
good health, abundant evidence exists also suggesting
that acute bouts of vigorous exercise could trigger
Table 1 Main characteristics of the marathon (n = 4) and half-marathon (n = 4) runners




26.5 ± 15.0 22.4 ± 1.9 199.0 ± 8.8 12.7 ± 0.6 5.3 ± 6.5
Half-marathon
(mean ± SD)
39.3 ± 13.6 23.6 ± 3.2 132.3 ± 4.5 9.6 ± 0.3 1.2 ± 0.3
BMI body mass index
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Table 2 Post-race changes in laboratory variables, change from baseline (%)
3-h post-race 48-h post-race
Marathon Half-marathon Marathon Half-marathon
Myoglobin 2451 977 −14 −6
Creatine kinase 385 85 297 124
Troponin T 1744 850 98 34
Brain natriuretic peptide 226 88 93 2
Creatinine 18 34 −5 9
Aspartate aminotransferase 84 23 164 32
Alanine aminotransferase 1 3 73 10
Uric acid 30 18 0.5 3
Cortisol 87 59 −23 8
Lactate 76 0 −11 24
Fig 1 Individual changes in mediators of inflammation in recreational athletes after running either a marathon or half-marathon race. *p < 0.05,
**p < 0.01, and ***p < 0.001 for comparisons between pre- and post-race values of all runners at given time points. §p < 0.05 and §§p < 0.01 for
comparisons of changes in values between full- and half-marathon runners. The highest levels of suPAR, CRP, IL-6, TNF-α, and IL-10 were noted
from a marathon runner who also suffered from the most severe symptoms of post-race fatigue (case indicated by arrows). CD163 macrophage
receptor for haptoglobin-hemoglobin complexes, CRP C-reactive protein, IL interleukin, suPAR soluble urokinase-type plasminogen activator
receptor, TGF-β transforming growth factor-β, TNF-α tumor necrosis factor-α, WBC white blood cells (leukocytes)
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Table 3 Correlations (r) between changes in biomarker levels, as calculated from percent change (pre to 3 h post) for each outcome variable
suPAR CD163 CRP WBC IL-6 IL-8 TNF-α IL-10 TGF-β Uric acid Cortisol Myoglobin Troponin T Creatinine
CD163 0.739**
CRP 0.358 0.561
WBC −0.426 −0.521 −0.352
IL-6 0.654* 0.032 −0.001 0.117
IL-8 0.631* 0.926**** 0.570 −0.196 0.052
TNF-α 0.729** 0.644* 0.055 −0.291 0.327 0.733**
IL-10 0.779** 0.711** 0.139 −0.367 0.359 0.723** 0.898***
TGF-β −0.107 −0.417 −0.062 0.048 0.091 −0.476 −0.781** −0.503
Uric acid 0.782** 0.510 0.209 −0.342 0.725** 0.692* 0.103 0.649* 0.165
Cortisol 0.632* 0.683* 0.050 −0.193 0.083 0.719** 0.877*** 0.934**** −0.670* 0.243
Myoglobin 0.245 0.369 0.634* −0.145 0.019 0.648* 0.130 −0.241 0.249 0.589 −0.103
Troponin T 0.455 0.364 0.712** 0.081 0.345 0.331 −0.208 −0.154 0.228 0.318 −0.105 0.690*
Creatinine 0.469 0.188 −0.571 0.286 0.360 0.130 0.139 0.296 −0.151 0.500 0.221 0.191 0.145
Lactate 0.495 0.544 0.705* −0.291 −0.035 0.631* 0.189 0.401 −0.247 0.043 0.342 0.028 0.635* −0.216
For abbreviations, see Fig. 1 caption
















adverse consequences [1, 2]. Thus, there is an apparent
need for additional information on the primary mecha-
nisms of exercise-induced health effects and screening
tools to prevent any possible adverse effects. Our
present observations on non-elite recreational runners
demonstrate distinct changes in the biomarkers of
inflammation after marathon and even after only half-
marathon running. There were also notable differences
in the patterns of the individual responses to these two
types of acute exercise bouts. While rather similar
increases were noted in white blood cell counts, the
response to marathon running was more pronounced
in the markers of immune activation (suPAR, CD163)
and the pro- (IL-8) and anti-inflammatory (IL-10) cyto-
kines. Changes in marathon runners’ results also coin-
cided with notable increases in biomarkers of various
organ functions despite that the sample of marathon
runners investigated represented individuals with more
rigorous training backgrounds.
To our knowledge, the data presented here provides the
first demonstration to indicate that prolonged running
elevates the concentrations of soluble urokinase plasmino-
gen activator receptor (suPAR) and the endocytic receptor
for haptoglobin-hemoglobin complexes (CD163) in serum.
While the former is present on various immunologically
active cells, the latter is found exclusively on macrophages
and monocytes. Previously, suPAR has been shown to be
elevated in conditions involving severe systemic inflamma-
tion [14–16]. Studies in patients from emergency units have
further indicated that suPAR levels also associate with dis-
ease prognosis. It serves as an early marker for developing
critical conditions [19–21]. In an analogous manner, serum
soluble CD163 has been implicated as an independent risk
marker in inflammatory states [17]. Under conditions of
inflammation and oxidative stress, CD163 can be released
rapidly into the plasma, and it is believed to mediate an
innate immune defense by sequestering hemoglobin-bound
iron. This macrophage-specific receptor can also protect
the individual from tissue damage by scavenging oxidative
stress-induced by-products of hemoglobin [18]. It should
also be noted that recent studies have emphasized an
immunomodulatory role of macrophages in conferring
cardioprotection [22]. Therefore, the findings that mara-
thon running increases the levels of this macrophage-
specific marker of immune activation is of note and should
be considered in further trials on the relationships between
inflammation and strenuous exercise.
The present observations show significant parallel in-
creases in both pro- (IL-6, IL-8) and anti-inflammatory
(IL-10) cytokines suggesting that such responses may be
required for counteracting the inflammatory threat, con-
trol of tissue damage and maintenance of body function
during prolonged strenuous exercise. Both IL-6 and IL-
10 have been shown to be associated with stimulation of
the Th2 pathway and activation of anti-inflammatory
cascades, and they may also inhibit TNF-α, which is a
potent mediator of tissue damage [12, 23–25]. Although
the mediators of inflammation here correlated with
TNF-α, the actual change in the latter did not, however,
reach significance. The most marked cytokine responses
were found to precede an increase in CRP, a conven-
tional biomarker of acute phase response and of sys-
temic inflammation. Interestingly, the highest values of
CRP, suPAR, IL-6, IL-10, and serum cortisol were all
found to occur in the case with the most severe post-
race symptoms of fatigue, which may support the view
that the status of inflammation may play a role as a
determinant of performance and the stress of running a
marathon. Post-race increases in serum cortisol, even
despite of its notable circadian variation, also showed
positive correlations with increases in the mediators of
inflammation which is in line with the view suggesting
an important immunomodulatory function for serum
cortisol in response to exercise [26]. Current findings
should be considered in the assessment of possible post-
race susceptibility to infections in long-distance runners
and, in particular, the relatively undertrained [27].
IL-6, which showed consistent changes as a result of both
marathon and half-marathon running, has previously been
shown to play a role in the regulation of acute phase
response, hematopoiesis, and tissue regeneration [12]. Its
systemic effects beyond the above may also include effects
on the liver and the adipose tissue. Interestingly, cytokine
responses, as released from muscle cells (myokines), have
been recently suggested to contribute to the beneficial
health effects of physical exercise and to serve as mediators
of developing physical fitness [11]. There also seems to be a
relationship with IL-6 responses and the intensity of the
exercise [9, 11]. IL-6 has further been implicated in protect-
ive signaling against ischemic injury in the heart [13]. The
primary mechanisms of interactions between IL-6 secretion
from exercised muscles and its communication among
muscles and other organs in conveying such protection
have, however, remained largely unknown [11, 13].
An excessive release of pro-inflammatory cytokines
can increase the production of reactive oxygen species
and thereby serve as a trigger for oxidative stress in tis-
sues [28]. In accordance with this view, the present data
shows consistent post-race increases in white blood cells
among both marathon and half-marathon participants.
In marathon runners, an enhanced expression was also
notable for pro-inflammatory IL-8, which is known for
its ability to attract neutrophils. The changes in the
mediators of inflammation coincided with an increase in
serum uric acid, which due to its free radical scavenging
properties can be considered a sign of an increased need
of antioxidant capacity during strenuous exercise and
associated free radical generation and lipid peroxidation
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[29, 30]. Significant correlations between acute post-race
changes in the levels of serum uric acid, suPAR, and IL-
6 also support a synergistic relationship between the
status of inflammation and generation of oxidative stress
[31]. Future studies should therefore be conducted to
address the possibility of whether the use of antioxidants
could influence post-race cytokine levels and the overall
function of the immune system.
In the present series, the biomarkers of muscle injury
used showed greater than 20-fold increases in marathon
runners and greater than 10-fold increases in half-
marathon runners. There was also a slight increase in
serum creatinine, a marker of kidney function, which is
notable in light of the fact that the release of excess
muscle-derived proteins upon prolonged vigorous exercise
can increase the risk of kidney damage [32–34]. Distinct
changes were also noted in troponin T, a marker of myo-
cardial damage. Previous studies have frequently reported
increased serum troponin levels in some marathon fin-
ishers, although the pathogenic significance of such obser-
vations has remained unknown [5, 7, 35–37]. It is possible
that enhanced myocardial wall oxidative stress together
with impaired endothelial function can increase the risk of
atherothrombotic events in susceptible individuals [38].
Alterations in cardiomyocyte function due to acute bouts
of strenuous exercise could be mediated by activation of
inflammation and oxidative stress, although the marked
elevations in proBNP levels also suggest exercise-induced
mechanical load in myocardium [7, 37, 39].
An obvious limitation of the present study is the small
sample size. A post hoc power analysis based on the
observed means and standard deviations in this present
work suggested, however, a sufficient statistical power for
all key findings at the recommended 0.80 level with alfa
set at the conventional 0.05 level. Thus, the occurrence of
type I error in the present material is unlikely. The small
number of subjects may, however, have impaired our
chances of reaching statistical significances in some of the
comparisons. Nevertheless, the data demonstrates distinct
changes in the serum levels of mediators of inflammation
as a result of full- or half-marathon running performed by
typical non-elite recreational athletes. These findings
should be considered when evaluating the acute health ef-
fects of extreme sports with long durations. The observed
changes in the normal balance of the circulating mediators
of inflammation and their possible association with tissue
damage, oxidative stress, and functioning of the immune
system warrant further study in larger numbers.
Conclusions
Strenuous physical activity activates immune reactions.
However, few studies exist, observing exercise-induced,
simultaneous changes in mediators of inflammation. In
eight participants, who successfully completed the half
(n = 4) or full (n = 4) marathon run, significant post-race
increases occurred in levels of (1) suPAR, a biomarker of
immune activation; (2) CD163, a biomarker of monocyte-
macrophage activation; (3) CRP, a biomarker of acute
phase response; and (4) pro- (IL-6, IL-8) and anti-
inflammatory (IL-10) cytokines. While the marathon
increased all parameters, half-marathon finishers showed
elevated levels of IL-6 and white blood cell counts only.
The highest suPAR, CRP, IL-6, TNF-α, IL-10, and cortisol
levels were noted in the individual presenting with the
most severe post-race fatigue. The data indicates that pro-
longed running increases mediators of inflammation in an
exercise-dose-dependent manner which may influence
post-race immune function in long-distance runners and,
in particular, the relatively undertrained. The observed
changes in the normal balance of the circulating mediators
of inflammation and their possible association with tissue
damage, oxidative stress, and post-race susceptibility to
infections warrant further studies in larger populations.
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